Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carcinoma and the peripheral nervous system

R Hughes1, B Sharrack, R Rubens

  • 1Department of Neurology, UMDS, Guy's Hospital, London, UK.

Journal of Neurology
|May 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with 'aggressive' multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2021
Same author

WITHDRAWN: Assessment of the inter-laboratory repeatability of gait analysis measurements in patients with multiple sclerosis.

Gait & posture·2021
Same author

Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Working Party (ADWP) of the European Society of Bone and Marrow Transplantation (EBMT).

Bone marrow transplantation·2019
Same author

Gold nanoparticle-based colorimetric biosensors.

Nanoscale·2017
Same author

Measurement of the WZ production cross section in pp collisions at [Formula: see text] and 8[Formula: see text] and search for anomalous triple gauge couplings at [Formula: see text].

The European physical journal. C, Particles and fields·2017
Same author

Relative Modification of Prompt ψ(2S) and J/ψ Yields from pp to PbPb Collisions at sqrt[s_{NN}]=5.02  TeV.

Physical review letters·2017

Peripheral neuropathy can indicate an underlying carcinoma, especially paraneoplastic sensory neuronopathy. Autoantibodies, like anti-Hu, are key diagnostic markers for detecting occult cancers and guiding treatment strategies.

Area of Science:

  • Neurology
  • Oncology
  • Immunology

Background:

  • Peripheral neuropathy is a potential presenting feature of an underlying carcinoma.
  • Diagnosis can be challenging when neuropathy precedes established malignancy.
  • Paraneoplastic syndromes, particularly sensory neuronopathy, are associated with specific autoantibodies.

Purpose of the Study:

  • To highlight the significance of peripheral neuropathy as an early sign of occult malignancy.
  • To discuss the role of autoantibodies, such as anti-Hu, in diagnosing paraneoplastic sensory neuronopathy.
  • To review treatment-related neuropathies in cancer patients and potential therapeutic strategies.

Main Methods:

  • Review of clinical presentations of neuropathy in cancer patients.
  • Discussion of diagnostic utility of autoantibodies against neuronal antigens.

Related Experiment Videos

  • Analysis of mechanisms of treatment-induced neurotoxicity.
  • Main Results:

    • Autoantibodies to neuronal antigens, especially anti-Hu antibodies, are valuable markers for underlying carcinoma in paraneoplastic sensory neuronopathy.
    • Direct nerve compression by tumors is identifiable in established malignancy.
    • Neuropathy during cancer treatment can result from radiation or chemotherapy neurotoxicity.

    Conclusions:

    • Peripheral neuropathy warrants investigation for an underlying carcinoma, particularly in cases of paraneoplastic sensory neuronopathy.
    • Anti-Hu antibodies are crucial diagnostic markers for paraneoplastic sensory neuronopathy associated with occult cancers.
    • Understanding neurotoxicities of cancer treatments and exploring neurotrophic factors are important for patient management.